Multicentre trials review process by research ethics committees in Spain: Where do they stand before implementing the new European regulation?

Journal of Medical Ethics

Volumn 31, Issue 6, 2005, Pages 344-350

  Dal Ré, Rafael ^a   Ortega, R ^a   Morejon E ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PLACEBO; VACCINE;

ADD ON THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; EUROPEAN UNION; GOVERNMENT REGULATION; HUMAN; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PROFESSIONAL STANDARD; PROSPECTIVE STUDY; RESEARCH ETHICS; REVIEW; SPAIN; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

CLINICAL PROTOCOLS; CLINICAL TRIALS; ETHICS COMMITTEES, RESEARCH; EUROPEAN UNION; FEMALE; HUMANS; MALE; MULTICENTER STUDIES; PEER REVIEW, RESEARCH; SPAIN; TIME FACTORS;

EID: 20444433598     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2003.007492     Document Type: Review

References (33)

1. Watling MIL, Dewhurst JK. Current experience of central versus local ethics approval in multicentre studies. J R Coll Physicians Lond 1993;27:399-402.
2. Hotopf M, Wesseley S, Noah A. Are ethics committees reliable. J R Soc Med, 1995;88:31-3.
3. Dal-Re R, Espada J, Ortega R. Performance of research ethics committees in Spain. A prospective study of 100 applications for clinical trial protocols on medicines. J Med Ethics 1999; 25:268-73.
4. Burman WJ, Reves RR, Cohn DL, et al. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med 2001;134:152-7.
5. Boyce M. Observational study of 353 applications to London multicentre research ethics committee 1997-2000. BMJ 2002; 325:1081.
6. Mann H. Research ethics committees and public dissemination of clinical trial results. Lancet 2002; 360:406-8.
7. Pich J, Carné X, Arnaiz JA, et al. Role of a research ethics committee in follow-up and publication of results. Lancet 2003;361:1015-16.
8. Office of Inspector General. Department of Health and Human Services. Institutional Review Boards: a time for reform, June 1998.OEI-01-97-00193.http://oig.hhs.gov/oei/reports/ (accessed 11 July 2002).
9. Lucena MI, Bosch F, Baños JE. Diez años de comités éticos de investigación clínica: los riesgos de la complacencia. Medicina Clinica (Barcelona) 2003; 120:257-60.
10. Humphreys K, Trafton J, Wagner TH. The cost of Institutional Review Board procedures in multicenter observational research. Ann Intern Med 2003;139:77.
11. NHS Executive. Ethics committee review of multicentre research. London: Department of Health, 1997, HSG (97), 23.
12. NHS Executive. Interim guidance: How should an LREC handle an MREC approved application? London: Department of Health, 1998.
13. Alberti KGMM. Multicentre research ethics committees: has the cure been worse than the disease. BMJ 2000; 320:1157-8.
14. Real Decreto 561/1993, de 16 de abril, por el que se establecen los requisitos para la realización de ensayos clínicos con medicamentos. BOE 13 de mayo de, 1993.
15. Bianchi W, Furlani P, Alessi T, et al. Clinical trials: focus on Italy. Drug Inf J 2002;36:387-394.
16. Directive 2001/20/EC of the European parliament and the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities, 1 May 2001. L 121/34-44.
17. Loi No 88-1138, 20 décembre 1988 relative à la protection des personnes qui se pretent à des recherches biomédicales. Journal Officiel de la République Française, 22 décembre 1988: 16032-5, Amendments:Loi No 90-86, 23 janvier 1990, Loi No 90-549, 2 juillet 1990, and Loi No 91-73, 18 juillet, 1991.
18. Avendaño C, Casas A, Dal-Re R, et al. Comités éticos de investigación clínica y "dictamen único" en los ensayos clínicos multicéntricos. Medicina Clínica (Barcelona) 2003; 120:180-8.
19. Keinonen T, Nieminen S, Saareks V, et al. Acceptability and profile of the clinical drug trials underway in Finnish university hospitlas in the 1990s: Applications reviewed by Ethics Committees. Methods Find Exp Clin Pharmacol 2001;23:415-23.
20. Godfrey E, Wray E, Nicholson R. Another look at LREC annual reports. Bull Med Ethics 2001;171:13-21.
21. Maskell NA, Jones EL, Davies RJO. Variations in experience in obtaining local ethical approval for participation in a multi-centre study. Q J Med 2003;96:305-7.
22. Huriet MC. Rapport d'information fait au nom de la commission des Affaires sociales sur le fonctionnement des comités consultatifs, de protection des personnes dans la recherche biomédicale. Sénat, session ordinaire de 2000-2001, No 267.
23. Meade TW. The trouble with ethics committees. J R Coll Physicians Lond 1994;28:102-3.
24. Lux AL, Edwards SW, Osborne JP. Responses of local research ethics committees to a study with approval from multicentre research ethics committee. BMJ 2000;320:1182-3.
25. Tully J, Ninis N, Boody R, et al. The new system of review of multicentre research ethics committees: a prospective study. BMJ 2000;320:1179-82.
26. Research Governance framework for Health and Social Care. Available at www.doh.gov.uk/research (accessed 2 August 2002).
27. Governance arrangements for NHS Research Ethics Committees. July 2001. Available at www.doh.gov.uk/research (accessed 2 August 2002).
28. Cave E, Holm S. New governance arrangements for research ethics committees: is facilitating research achieved at the cost of participants' interest. J Med Ethics 2002;28:318-21.
29. Agencia Española del Medicamento. Informe de actividades 2001-2002. Ministerio de Sanidad y Consumo, 2003.
30. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data on the free movement of such data. Official Journal L 281, 23 November, 1995:31-50.
31. Central Office for Research Ethics Committees. Central allocation system for applications to MRECs. Available at www.corec.org.uk/centralallocations.htm (accessed 12 June 2003).
32. Attuazione della direttiva 2001/20/CE relativa all'applicazione della buona pratica clinica nell'esecuzione delle sperimentazione cliniche di medicinali per uso clinico. Decreto Legislativo 24 giugno 2003, n 211. Gazzetta Ufficiale della Repubblica Italiana n 184 del 9-8-2003, Suppl Ordinario n 130.
33. Saunders J. Research ethics committees - time for change? Clin Med 2002;2:534-8.